Strata Critical Medical, Inc. SRTA
5.56 USD +0.30 (+5.70%)
At closeNov 6, 2026, 4:01 PM EST
5.56 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
5.16 Day range 5.62
4.03 52-week range 6.47
- YTD
- +15.59%
- 1 year
- +19.57%
News
defenseworld.net Strata Critical Medical Q3 Earnings Call Highlights Strata Critical Medical (NASDAQ: SRTA) reported fiscal third-quarter 2026 revenue growth of 50.3% from a year earlier, alongside higher adjusted EBITDA, improved logistics margins and record free…
globenewswire.com Strata Critical Medical to Present at the UBS Global Healthcare Conference NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the UBS Global Healthcare…
seekingalpha.com Strata Critical Medical, Inc. (SRTA) Q3 2026 Earnings Call Transcript Strata Critical Medical, Inc. (SRTA) Q3 2026 Earnings Call Transcript
marketbeat.com Strata Critical Medical Q3 Earnings Call Highlights Strata Critical Medical NASDAQ: SRTA reported fiscal third-quarter 2026 revenue growth of 50.3% from a year earlier, alongside higher adjusted EBITDA, improved logistics margins and record free cash…
benzinga.com Strata Critical Medical Q3 2026 Earnings Call Transcript Strata Critical Medical (NASDAQ:SRTA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Strata Critical Medical Affirms FY2026 Sales Guidance of $285.000M-$295.000M vs $290.804M Est Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $285.000 million-$295.000 million to $285.000 million-$295.000 million vs $290.804 million estimate.
benzinga.com Strata Critical Medical Q3 EPS $(0.09) Misses $(0.01) Estimate, Sales $74.081M Beat $72.669M Estimate Strata Critical Medical (NASDAQ:SRTA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.01) by 800 percent. This is a 25 percent increase over losses…
globenewswire.com Strata Critical Medical Announces Third Quarter 2026 Results Revenue increased 50.3% year-over-year to $74.1 million in Q3 2026 Clinical revenue increased 20.3% sequentially in Q3 2026 vs Q2 2026 Q3 2026 net loss from continuing operations of $(7.6) million or…
benzinga.com Crude Oil Jumps 3%; Citizens Financial Earnings Top Views U.S. stocks fell Friday, led by Nasdaq’s 1.86% drop; energy rose, communication services sank. Oil topped $100 as CFG beat earnings estimates.
benzinga.com Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed; Ladder Capital surged after beating Q3 estimates. Alcoa and other stocks also gained, led by Strata Critical Medical’s 7.5% rise.
benzinga.com Third Point's Daniel Loeb Urges Strata Critical Medical To Explore Strategic Alternatives Including Potential Sale The Reporting Persons acquired the securities reported herein for investment purposes and believe that the Common Stock is undervalued. The Reporting Persons believe that the underlying business of…
benzinga.com Strata Critical Medical Q2 2026 Earnings Call Transcript Strata Critical Medical (NASDAQ:SRTA) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs.…- benzinga.com Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript On Tuesday, Strata Critical Medical (NASDAQ:SRTA) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by…
- benzinga.com Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.
benzinga.com Strata Critical Medical Acquires Heart And Lung Transplant National Recovery Program For $21.5M Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Heart and Lung Transplant National Recovery Program ("HLT-NRP"),- benzinga.com Strata Critical Medical Acquires Louisville Perfusion Services In All-Cash Transaction Worth Up To $20M Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company"))), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. ("LPS"), a regional provider of…
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Strata Critical Medical Q1 2026 Earnings Call: Complete Transcript 
benzinga.com Strata Critical Medical Affirms FY2026 Sales Guidance of $260.000M-$275.000M vs $269.175M Est Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $260.000 million-$275.000 million to $260.000 million-$275.000 million vs $269.175 million estimate.
benzinga.com Strata Critical Medical Q1 EPS $0.03 Beats $(0.04) Estimate, Sales $67.384M Beat $63.675M Estimate Strata Critical Medical (NASDAQ:SRTA) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.04) by 175 percent. This is a 175 percent increase over losses of…- benzinga.com Strata Critical Medical Acquires Ohio Valley Perfusion Associates For ~$1M Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of…
benzinga.com Cathie Wood Slams The Brakes — Ark Invest Sits Out As S&P 500 Smashes Records Ark Invest made no trades in its six main ETFs for two straight days, a rare feat. Here's how the ETFs are performing in 2026.- benzinga.com Craig-Hallum Initiates Coverage On Strata Critical Medical with Buy Rating, Announces Price Target of $8 Craig-Hallum analyst Bill Bonello initiates coverage on Strata Critical Medical (NASDAQ:SRTA) with a Buy rating and announces Price Target of $8.
benzinga.com B. Riley Securities Initiates Coverage On Strata Critical Medical with Buy Rating, Announces Price Target of $8 B. Riley Securities analyst Yuan Zhi initiates coverage on Strata Critical Medical (NASDAQ:SRTA) with a Buy rating and announces Price Target of $8.
benzinga.com Ingram Micro Posts Upbeat Q4 Earnings, Joins Ziff Davis, Kontoor Brands, Lendingtree And Other Big Stocks Moving Higher On Tuesday Dow falls over 1,100 points as shares of Ingram Micro jump 11.8% on better-than-expected earnings. Other big gainers include Plug Power, Paysafe, and Strata Critical Medical.
benzinga.com Strata Critical Medical Raises FY2026 Sales Guidance from $255.000M-$270.000M to $260.000M-$275.000M Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $255.000 million-$270.000 million to $260.000 million-$275.000 million.- benzinga.com Strata Critical Medical Q4 Sales $66.787M Beat $60.350M Estimate Strata Critical Medical (NASDAQ:SRTA) reported quarterly sales of $66.787 million which beat the analyst consensus estimate of $60.350 million by 10.67 percent. This is a 22.87 percent increase over…
- benzinga.com Earnings Scheduled For March 3, 2026
benzinga.com BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket 
benzinga.com Earnings Scheduled For November 10, 2025 
benzinga.com Ferguson Enterprises, WEBTOON Entertainment, Jumia Technologies And Other Big Stocks Moving Higher On Tuesday